<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To report the prevalence of <z:hpo ids='HP_0100633'>esophagitis</z:hpo> in patients with pH-documented <z:e sem="disease" ids="C1168250" disease_type="Disease or Syndrome" abbrv="">laryngopharyngeal reflux</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>STUDY DESIGN: Prospective study of 58 consecutive patients with documented <z:e sem="disease" ids="C1168250" disease_type="Disease or Syndrome" abbrv="">laryngopharyngeal reflux</z:e>, <z:hpo ids='HP_0000001'>all</z:hpo> of whom underwent transnasal esophagoscopy as part of their reflux evaluations </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: <z:hpo ids='HP_0000001'>All</z:hpo> patients with a diagnosis of <z:e sem="disease" ids="C1168250" disease_type="Disease or Syndrome" abbrv="">laryngopharyngeal reflux</z:e> confirmed by abnormal pharyngeal pH monitoring over a 5-month period were included, and <z:hpo ids='HP_0000001'>all</z:hpo> subjects completed a self-administered reflux symptom index and underwent transnasal esophagoscopy with directed biopsy </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Of the 58 study patients with pH-documented <z:e sem="disease" ids="C1168250" disease_type="Disease or Syndrome" abbrv="">laryngopharyngeal reflux</z:e>, the mean age was 49 years (+/- 13 y), and 53% (31 of 58) were women </plain></SENT>
<SENT sid="4" pm="."><plain>Of the study group, 40% (23 of 58) had heartburn and 48% (28 of 58) had abnormal <z:e sem="disease" ids="C0017168,C0559234" disease_type="Disease or Syndrome;Finding" abbrv="">esophageal reflux</z:e> (by pH monitoring criteria); by transnasal esophagoscopy with biopsy, 12% (7 of 58) had <z:hpo ids='HP_0100633'>esophagitis</z:hpo> and another 7% (4 of 58) had Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Thus, 60% of the study cohort had heartburn, and 81% (47 of 58) had <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal epithelium (i.e., <z:hpo ids='HP_0100633'>esophagitis</z:hpo> or Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath>) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: In the present series of patients with documented <z:e sem="disease" ids="C1168250" disease_type="Disease or Syndrome" abbrv="">laryngopharyngeal reflux</z:e> the prevalence of <z:hpo ids='HP_0100633'>esophagitis</z:hpo> and Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> was only 19% </plain></SENT>
<SENT sid="7" pm="."><plain>These data confirm the clinical impression that the patterns, mechanisms, and manifestations of <z:e sem="disease" ids="C1168250" disease_type="Disease or Syndrome" abbrv="">laryngopharyngeal reflux</z:e> differ from those of classic <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Unlike <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo>, patients with <z:e sem="disease" ids="C1168250" disease_type="Disease or Syndrome" abbrv="">laryngopharyngeal reflux</z:e> uncommonly have <z:hpo ids='HP_0100633'>esophagitis</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, although esophagoscopy may be an excellent method for screening the esophagus, it is not the method of choice for diagnosing <z:e sem="disease" ids="C1168250" disease_type="Disease or Syndrome" abbrv="">laryngopharyngeal reflux</z:e> </plain></SENT>
</text></document>